Literature DB >> 2851002

NMDA receptor channels: labeling of MK-801 with iodine-125 and fluorine-18.

D M Wieland1, M R Kilbourn, D J Yang, E Laborde, D L Gildersleeve, M E Van Dort, J L Pirat, B J Ciliax, A B Young.   

Abstract

Methods for labeling the glutamate channel blocking agent MK-801 with iodine-125 (125I) and fluorine-18 (18F) are described. Radioiodine was incorporated in the 1- or 3-positions of the aromatic ring of (+/-)MK-801 by solid-state halogen exchange techniques. Attachment of the [18F]fluoromethyl group to the bridgehead methyl position was achieved by reaction of [18F]fluoride with the triflamide alcohol 8 or the novel cyclic sulfamate 9 recently reported by Merck chemists. Radiochemical yields of (+/-) 13-[18F]-fluoromethyl-MK-801 were greater than 72%, EOB; radiochemical purity greater than 99%. In competitive binding studies using rat brain homogenates, (+/-)3-bromo-MK-801 showed greater affinity than (+/-)MK-801 for the glutamate-linked channel. The experimental log P (2.1 +/- 0.1) of MK-801 is optimal for transit of the blood-brain barrier. These preliminary findings support further testing of 3-[123 I]iodo-MK-801 and (+/-)13-[18F]fluoromethyl-MK-801 as possible agents for in vivo mapping of the glutamate receptor complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851002     DOI: 10.1016/0883-2889(88)90103-7

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum A        ISSN: 0883-2889


  2 in total

Review 1.  Pharmacological implications for neuroreceptor imaging.

Authors:  N P Verhoeff
Journal:  Eur J Nucl Med       Date:  1991

2.  Synthesis and in vitro receptor binding studies of fluorotamoxifen analogues.

Authors:  D J Yang; S Wallace; W Tansey; K C Wright; L R Kuang; R S Tilbury; I Diego; J L Lim; A M Emran; E E Kim
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.